MedTrace Logo

Clinical Trial of Autologous Adipose Derived Regenerative Cells for the Treatment of Male Stress Urinary Incontinence

NCT02529865 · Status: COMPLETED · Phase: PHASE3 · Type: INTERVENTIONAL · Enrollment: 45

Last updated 2019-11-14

No results posted yet for this study

Summary

The purpose of this study is to evaluate the efficacy and safety of periurethral injection of autologous Adipose Derived Regenerative Cells (ADRCs) in male stress urinary incontinence.

Conditions

  • Urinary Incontinence , Stress

Interventions

BIOLOGICAL

Periurethral injection of autologous ADRCs and adipose tissue

1 mL of the isolated ADRC is injected into the region of the external urethral sphincter, and another 4 mL of the ADRC and 16mL autologous adipose cells is injected under the urethral mucosa.

Sponsors & Collaborators

  • Nagoya University

    lead OTHER

Principal Investigators

  • Momokazu Gotoh, M.D., Ph.D. · Department of Urology

Study Design

Allocation
NA
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
20 Years
Sex
MALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2015-07-29
Primary Completion
2019-03-07
Completion
2019-03-07

Countries

  • Japan

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02529865 on ClinicalTrials.gov